Xaluprine (previously Mercaptopurine Nova Laboratories)
Active substance: mercaptopurine
6-mercaptopurine monohydrate
Centralised EU authorisationActive
Marketing holder: Lipomed GmbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
- 6-mercaptopurine monohydrate
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 5 |
|
| US 7 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-b892-7e7b-b647-e94b1d929be8,01a120c4-3957-702d-b05e-2a8657a918cd,01a120c5-20bf-7324-a488-7174fe13fa96,01a120c6-7570-757f-afeb-0b83fae95fd8;count=4 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-b199-73bc-8139-c163292e870d,01a12092-1c8f-7958-baed-e9d9e32f19c6,01a12097-299d-794a-bb61-95c9b4722042,01a1209b-1cef-7511-bbc3-517bf435a170,01a1209b-7cb5-7351-a878-c394b2512c6c;count=7 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/002022
- Registration status
- Active
- ATC code
- L01BB02
Sources
- product · EMA · EMEA/H/C/002022 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002022 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002022 · Verified 2026-10-09